Cargando…

Association between the TIMD4-HAVCR1 variants and serum lipid levels, coronary heart disease and ischemic stroke risk and atorvastatin lipid-lowering efficacy

Little is known about the association of the TIMD4 (T-cell immunoglobulin and mucin domain 4 gene)-HAVCR1 (hepatitis A virus cellular receptor 1) variants and lipid metabolism, the risk of coronary heart disease (CHD) and ischemic stroke (IS). The present study aimed to determine the TIMD4-HAVCR1 va...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Qing-Hui, Yin, Rui-Xing, Chen, Wu-Xian, Cao, Xiao-Li, Chen, Yu-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773822/ https://www.ncbi.nlm.nih.gov/pubmed/29208769 http://dx.doi.org/10.1042/BSR20171058

Ejemplares similares

ANGPTL4 variants and their haplotypes are associated with serum lipid levels, the risk of coronary artery disease and ischemic stroke and atorvastatin cholesterol-lowering responses
por: Yang, Qian, et al.
Publicado: (2018)

TIMD4 rs6882076 SNP Is Associated with Decreased Levels of Triglycerides and the Risk of Coronary Heart Disease and Ischemic Stroke
por: Khounphinith, Eksavang, et al.
Publicado: (2019)

TRIB1 and TRPS1 variants, G × G and G × E interactions on serum lipid levels, the risk of coronary heart disease and ischemic stroke
por: Zhang, Qing-Hui, et al.
Publicado: (2019)

The effect of MVK-MMAB variants, their haplotypes and G×E interactions on serum lipid levels and the risk of coronary heart disease and ischemic stroke
por: Miao, Liu, et al.
Publicado: (2017)

Development of Timd2 as a reporter gene for MRI
por: Patrick, P. Stephen, et al.
Publicado: (2015)

Association of the HNF1A polymorphisms and serum lipid traits, the risk of coronary artery disease and ischemic stroke
por: Zhou, Yi‐Jiang, et al.
Publicado: (2017)

Efficacy and safety of Zhibitai in combination with atorvastatin for lipid lowering in patients with coronary heart disease
por: Xu, Danyan, et al.
Publicado: (2017)

DOCK7-ANGPTL3 SNPs and their haplotypes with serum lipid levels and the risk of coronary artery disease and ischemic stroke
por: Li, Wei-Jun, et al.
Publicado: (2018)

MADD-FOLH1 Polymorphisms and Their Haplotypes with Serum Lipid Levels and the Risk of Coronary Heart Disease and Ischemic Stroke in a Chinese Han Population
por: Wu, Dong-Feng, et al.
Publicado: (2016)

The influence of MRAS gene variants on ischemic stroke and serum lipid levels in Chinese Han population
por: Song, Yan, et al.
Publicado: (2019)

Correlations Between TIMD-4 Gene Variants and the Risk and Clinical Features of Rheumatoid Arthritis in a Chinese Population
por: Yang, Zhicheng, et al.
Publicado: (2021)

DGAT2-MOGAT2 SNPs and Gene-Environment Interactions on Serum Lipid Profiles and the Risk of Ischemic Stroke
por: Zhou, Yong-Gang, et al.
Publicado: (2021)

Cholesteryl Ester Transfer Protein Gene and Effectiveness of Lipid Lowering of Atorvastatin
por: Kolovou, Genovefa, et al.
Publicado: (2010)

Functional variants of TIM-3/HAVCR2 3′UTR in lymphoblastoid cell lines
por: Pu, Feifei, et al.
Publicado: (2018)

The Role of Lipid-Lowering Treatment in the Secondary Prevention of Ischemic Stroke
por: Tsankof, Alexandra, et al.
Publicado: (2021)

Association between the PPP1R3B polymorphisms and serum lipid traits, the risk of coronary artery disease and ischemic stroke in a southern Chinese Han population
por: Li, Wei-Jun, et al.
Publicado: (2018)

Association between the XKR6 rs7819412 SNP and serum lipid levels and the risk of coronary artery disease and ischemic stroke
por: Zheng, Peng-Fei, et al.
Publicado: (2019)

Effect of SYTL3-SLC22A3 Variants, Their Haplotypes, and G × E Interactions on Serum Lipid Levels and the Risk of Coronary Artery Disease and Ischaemic Stroke
por: Zheng, Peng-Fei, et al.
Publicado: (2021)

Combination therapy of atorvastatin and probucol on ischemic stroke in clinic
por: Yan, Tao, et al.
Publicado: (2012)

The effects of different doses of atorvastatin on serum lipid profile, glycemic control, and liver enzymes in patients with ischemic cerebrovascular accident
por: Sadeghi, Roxana, et al.
Publicado: (2014)

Serum lipid profiles and post-stroke depression in acute ischemic stroke patients
por: Shen, Huiping, et al.
Publicado: (2019)

Association of genetic variations with pharmacokinetics and lipid-lowering response to atorvastatin in healthy Korean subjects
por: Woo, Hye In, et al.
Publicado: (2017)

Effects of atorvastatin on serum lipids, serum inflammation and plaque morphology in patients with stable atherosclerotic plaques
por: GUO, SUXIA, et al.
Publicado: (2012)

RIPK3 modulates sarcoma through immune checkpoint HAVCR2
por: Qian, Chen, et al.
Publicado: (2022)

Effect of CETP Polymorphism on Atorvastatin Lipid-Regulating Effect and Clinical Prognosis of Patients with Coronary Heart Disease
por: Gu, Guo-Long, et al.
Publicado: (2014)

Lipids and Lipid Mediators Associated with the Risk and Pathology of Ischemic Stroke
por: Kloska, Anna, et al.
Publicado: (2020)

Vitamin D Levels and Lipid Response to Atorvastatin
por: Pérez-Castrillón, José Luis, et al.
Publicado: (2010)

Treatment of an HLH-mimic disease based on HAVCR2 variants with absent TIM-3 expression
por: Tromp, Samantha A.M., et al.
Publicado: (2022)

Immediate effect of intensive atorvastatin therapy on lipid parameters in patients with acute coronary syndrome
por: Vondrakova, Dagmar, et al.
Publicado: (2010)

Sex-Specific Influence of the SCARB1 Rs5888 SNP on the Serum Lipid Response to Atorvastatin in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Wu, Dong-Feng, et al.
Publicado: (2020)

Changes in Homocysteine Levels Affect Serum Lipid Response to Atorvastatin in Patients With Acute Coronary Syndrome: A Retrospective Observational Study
por: Wu, Dong-Feng, et al.
Publicado: (2020)

Zhibitai and low-dose atorvastatin reduce blood lipids and inflammation in patients with coronary artery disease
por: Zhao, Yuhong, et al.
Publicado: (2017)

Circulating Lipoprotein Lipids, Apolipoproteins and Ischemic Stroke
por: Yuan, Shuai, et al.
Publicado: (2020)

Lipid-Lowering Therapy in Patients with Coronary Heart Disease and Prior Stroke: Mission Impossible?
por: Temporelli, Pier Luigi, et al.
Publicado: (2021)

Protective lipid-lowering variants in healthy older individuals without coronary heart disease
por: Lacaze, Paul, et al.
Publicado: (2021)

Use of Atorvastatin in Lipid Disorders and Cardiovascular Disease in Chinese Patients
por: Ye, Yi-Cong, et al.
Publicado: (2015)

Impact of the Gut Microbiota on Atorvastatin Mediated Effects on Blood Lipids
por: Zimmermann, Friederike, et al.
Publicado: (2020)

Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study
por: Berne, Christian, et al.
Publicado: (2005)

Serum lipid level is not associated with symptomatic intracerebral hemorrhage after intravenous thrombolysis for acute ischemic stroke
por: Lin, Ting-Chun, et al.
Publicado: (2018)

XKR6 rs7014968 SNP Increases Serum Total Cholesterol Levels and the Risk of Coronary Heart Disease and Ischemic Stroke
por: Li, Kai-Guang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c168g3deat63t015dtruo730ql